← Back to Search

Unknown

TERN-201 for Non-alcoholic Fatty Liver Disease

Phase 1
Waitlist Available
Research Sponsored by Terns, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This trial is testing a new drug to treat NASH, a fatty liver disease. The drug will be given to patients to see if it is safe and effective.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subject incidence of adverse events for TERN-201 versus placebo
Secondary outcome measures
Percent Change from baseline in plasma VAP-1/SSAO activity
Plasma concentration of TERN-201- AUC
Plasma concentration of TERN-201- Cmax
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Part 2: TERN-201 dose level 2Experimental Treatment1 Intervention
Orally administered
Group II: Part 1: TERN-201 dose level 1Experimental Treatment1 Intervention
Orally administered.
Group III: Part 1: PlaceboPlacebo Group1 Intervention
Orally Administered
Group IV: Part 2: PlaceboPlacebo Group1 Intervention
Orally administered
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TERN-201
2021
Completed Phase 1
~60

Find a Location

Who is running the clinical trial?

Terns, Inc.Lead Sponsor
3 Previous Clinical Trials
343 Total Patients Enrolled
2 Trials studying Non-alcoholic Fatty Liver Disease
263 Patients Enrolled for Non-alcoholic Fatty Liver Disease
clinicaltrials@ternspharma.comStudy DirectorTerns, Inc.
1 Previous Clinical Trials
101 Total Patients Enrolled
1 Trials studying Non-alcoholic Fatty Liver Disease
101 Patients Enrolled for Non-alcoholic Fatty Liver Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis
2021. "AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04897594.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top